The bicyclic b-lactam/2-pyrrolidine precursor to all carbapenem antibiotics is biosynthesized by attachment of a carboxymethylene unit to C5 of L-proline followed by b-lactam ring closure. Carbapenem synthase (CarC), an Fe(II) and 2-(oxo)glutarate (Fe/2OG)-dependent oxygenase, then inverts the C5 configuration. Here we report the structure of CarC in complex with its substrate and biophysical dissection of its reaction to reveal the stereoinversion mechanism. An Fe(IV)-oxo intermediate abstracts the hydrogen (H•) from C5, and tyrosine 165, a residue not visualized in the published structures of CarC lacking bound substrate, donates H• to the opposite face of the resultant radical. The reaction oxidizes the Fe(II) cofactor to Fe(III), limiting wild-type CarC to one turnover, but substitution of the H•-donating tyrosine disables stereoinversion and confers to CarC the capacity for catalytic substrate oxidation.
b
-Lactam compounds constitute more than half of the global antibiotic drug market (1, 2) . In the past decade, the increased incidence of bacterial b-lactam resistance has forced increasing reliance on a relatively new subclass of these drugs known as carbapenems (Fig. 1A ) (2, 3) . Defined by the bicyclic b-lactam/pyrroline nucleus (1), carbapenems are generally less susceptible than many members of the b-lactam class to hydrolytic inactivation by b-lactamases. With more than 40 naturally occurring members, the carbapenem subclass retains activity against a broad range of both Gram-positive and Gram-negative bacteria, including Staphylococcus epidermidis, Staphylococcus aureus, and Pseudomonas aeruginosa (4) . An understanding of the biosynthetic pathways to these natural carbapenems could enable the engineering of new drug variants to combat resistance, which has been emerging at an alarming rate, even to this most robust b-lactam subclass (5) .
After the initial isolation of a carbapenem, thienamycin (2) , from Streptomyces cattleya in 1976 (6), the structurally simplest carbapenem, 1, was isolated from Erwinia carotovora (known also as Pectobacterium carotovorum) and other species (7) . Early biochemical studies identified the car gene cluster encoding the enzymatic apparatus to produce 1 (8, 9) . Later studies confirmed that this cluster is conserved in all strains that produce carbapenem and is distinct from gene clusters specifying penicillin and cephalosporin biosynthesis (2) . Introduction of the carA, carB, and carC genes into Escherichia coli established that the three encoded enzymes, carbapenam synthetase (CarA), carboxymethylproline synthase (CarB), and carbapenem synthase (CarC), are sufficient to produce 3, 4, and 1 and enabled in vitro dissection of the biosynthetic sequence (10) (Fig.  1A) . Using malonyl-coenzyme A (CoA) as cosubstrate, CarB attaches a carboxymethylene unit to 1-pyrroline-5-carboxylate (which may be supplied in carbapenem-producing microorganisms from L-proline by the carD gene product) to form trans-5-carboxymethyl-L-proline (11, 12) . CarA then uses adenosine 5´-triphosphate hydrolysis (to adenosine 5´-monophosphate and pyrophosphate) to drive b-lactam ring closure, generating (3S,5S)-carbapenam, 3 (13) . The stereochemical configuration at C5 established by CarB is opposite to that in all natural carbapenem antibiotics isolated to date (2) . Further elaboration of 3 apparently requires C5 stereoinversion by CarC, an Fe(II) and 2-(oxo)glutarate (Fe/2OG)-dependent oxygenase, which produces (3S,5R)-carbapenam, 4, as its initial product (10) . It has been concluded that only after inversion of C5 can CarC then desaturate across the C2-C3 bond to produce (5R)-carbapenem, 1 (14) . The R configuration at C5 and the C2=C3 double bond of 1 are both crucial for optimal antibiotic activity (15, 16) . To our knowledge, no CarB ortholog has yet been shown to produce the cis-5-carboxymethyl-L-proline, with C5 in the configuration found in the drug compounds (2, (17) (18) (19) . Moreover, although it has been suggested that C5 epimerases structurally and mechanistically unrelated to CarC might be operant in other carbapenem biosynthetic pathways [e.g., to thienamycin (17, 20) ], none has been identified to date. An understanding of the structure and function of CarC is thus central to efforts to bioengineer new carbapenems.
Mononuclear non-heme-iron oxidases and oxygenases, including those in the Fe/2OG subclass, generally effect oxidation of their primary substrates (21) . In the most well-understood cases, addition of O 2 to the Fe(II) cofactor and delivery of two electrons from a cosubstrate generates an Fe(IV)-oxo (ferryl) intermediate, which either abstracts a hydrogen atom (H•) from an aliphatic carbon of the substrate or adds as an electrophile to a double bond (22) . In cases of H• abstraction, an iron ligand then transfers as a radical to the substrate radical, completing the oxidative substitution of hydrogen by a heteroatom (O, Cl/Br, or S; Fig.  1B , reaction i). This step regenerates the Fe(II) form of the cofactor for subsequent turnovers (21) (22) (23) (24) .
By contrast to these oxidative substitution reactions, the CarC stereoinversion reaction is redox neutral with respect to its primary substrate, 3. This outcome has been rationalized by mechanisms invoking H• abstraction from C5 by the canonical ferryl species and subsequent transfer of a different H• to the opposite face of the substrate radical (Fig. 1B, reaction ii) by, presumably, an amino acid donor (X-H in Fig.  1B ) (25) . Computational analyses have supported such a mechanism and involvement of a dedicated H• donor (26) . A fluorescence-based in vivo assay for carbapenem production was coupled with amino acid mutagenesis to obtain data suggesting that tyrosine (Y) 67, visualized near the bound N-acetyl-L-proline intended to mimic the substrate in one of two published x-ray crystal structures of CarC, is the H• donor (27, 28) . The most recent of these studies used this structure for molecular-docking analysis that identified a hypothetical substrate-binding mode with C5 in sufficient proximity to Y67 for H• transfer (28) . However, because multiple segments of the protein are disordered in this structure, its use as a starting point for such an analysis is inherently speculative. Published mechanisms have further suggested that, after inverting C5, CarC then either uses the two oxidizing equivalents still present in the active site (Fig. 1A, pathway ii) or, following their reduction, undergoes a second round of O 2 activation and ferryl formation (pathway i), to effect C2-C3 desaturation (28) . As depicted, this second reaction is a mechanistically distinct twoelectron oxidation requiring removal of an H• equivalent from each of two adjacent carbon atoms (Fig. 1B, reaction iii) (28, 29) .
Studies on other Fe/2OG oxygenases and related oxidative enzymes have established that the crucial tenets of the proposed CarC stereoinversion mechanism, including H• abstraction by a ferryl intermediate and formation of a tyrosyl radical, could be definitively tested by rapid-kinetic and spectroscopic analysis of the reaction (22, 30, 31) . In addition, the structure of the enzyme with its authentic substrate, 3, would be expected to reveal proximity of C5 to the iron cofactor and the H• donor, as intentionally enforced for the case of Y67 in the recent computational study (28) . Instability of the substrate (7, 28, 32) and enzyme (28, 33) have repeatedly been cited as barriers to such direct in vitro mechanistic and structural analysis. To obtain the enzyme, we expressed N-terminally His 6 -affinity-tagged Pectobacterium carotovorum CarC in E. coli at 16°C and purified it on Ni(II)-nitrilo-tris-acetate agarose affinity resin, obtaining~30 mg of >90% pure protein per gram of wet cell mass ( fig. S1) . To obtain the substrate, we made use of the observation by multiple investigators that carboxylate-esterified analogs of 3 are sufficiently stable to be isolated (32, 34, 35) . We prepared the methyl ester of 3 (7) and its [5- . Following this deprotection, we found 3 to have a half-life of~14 hours at 25°C and pH 7.5 (in 100 mM Tris-chloride).
By this method of in situ deprotection, we overcame the long-standing barrier posed by the substrate's instability to determine both the structure of the CarC•Fe(II)•2OG•3 quaternary complex and the mechanism of C5 stereoinversion. To enable structural characterization, crystals of the CarC•Fe(II)•2OG ternary complex obtained after a~24-hour incubation in the absence of O 2 were soaked in freshly prepared anoxic solutions of 3 to form the quaternary complex, and the crystals were frozen before 3 could decompose (after 2 hours; see supplementary methods). The structure, solved at a resolution of 2.1 Å by x-ray diffraction experiments (table S1 and fig. S3 ), reveals three CarC molecules in the asymmetric unit (ASU). Significant electron density for carbapenam 3 is readily visualized in the active site of two of the three monomers ( Fig. 2A and fig. S4 ), but a crystal lattice contact that distorts the structure of the active site prevents proper substrate binding in the third molecule of the ASU ( fig. S5 ). The bridgehead C5 of 3 resides 4.4 Å from the iron site with its hydrogen directed toward the Fe cofactor in appropriate geometry for its abstraction by the ferryl intermediate ( Fig. 2B and fig.  S6 ). This binding orientation is unequivocally established by the shape of the electron density and the positioning of hydrogen-bonding residues to interact with the carboxylate and carbonyl groups of 3. The presence of the actual substrate [rather than the N-acetyl-L-proline bound in one of two published structures of CarC (36)] yields clear electron density for two previously disordered loops surrounding the active site ( fig. S4 ), allowing their structures to be modeled in two of the three molecules in the ASU. Residues 67 to 78 (loop 1) and 162 to 172 (loop 2) close over the active site, thereby isolating the substrate from bulk solvent. Such protection would seem to be critical for control of the free-radical reaction(s) mediated by CarC, a conclusion that is consistent with the results of recent mutational-saturation studies that showed that substitutions of bulky or aromatic residues in the active site are incompatible with activity (28) . In loop 1, Y67 and Y78 adopt new positions to participate with arginine (R) 267 and glutamine (Q) 269 in an extended hydrogen-bonding network that anchors the carboxylate of 3 in the binding pocket. Y164 in loop 2 also interacts directly with the carboxylate. The most mechanistically important change relative to published structures is the ordering of loop 2 to position Y165 directly above C5, opposite the iron center, with its hydroxyl group 4.8 Å from the substrate C5 atom (Fig. 2B) . In this position, Y165 is ideally poised to donate H• to the C5 radical to generate the (3S,5R) epimer, 4. By contrast, Y67, the residue suggested in previous work to be the H• donor (27, 28) , is positioned toward the edge of the substrate, inappropriately to serve in this capacity ( Fig. 2 and figs. S4 and S5) .
The structure of the CarC•Fe(II)•2OG•3 complex is consistent with key features of the published mechanisms, including abstraction of H• from C5 of 3 by the ferryl intermediate and transfer of H• to the opposite side of the C5 radical by a tyrosine, but it implies that Y165, a residue not visualized in any of the published structures and therefore never invoked in the mechanisms, is the dedicated H• donor (Fig. 2C ). To test these clear www.sciencemag.org SCIENCE VOL 343 7 MARCH 2014 functional implications, we dissected the mechanism by quantification of the reaction products (at completion and with time) and by rapid-kinetic and spectroscopic experiments on both wild-type and Y→F (phenylalanine) variant CarC proteins with both 3 and 5-d-3 substrates. All results are consistent with the chemical mechanism in Fig. 2C and the kinetic elaboration of this mechanism in fig. S7 . Crucial features revealed by the analysis are that the stereoinversion reaction is, in the absence of a reductant, stoichiometric (Fig. 1A , pathway i) rather than catalytic (pathway ii) as a result of oxidation of the Fe(II) cofactor to a stable Fe(III) form, and that only one-third of the enzyme's Fe(II) sites react, either because its quaternary structure (the trimeric ASU and overall hexamer seen in the crystal structure) enforces a "one-third-of-sites reactivity" or because the previously noted instability of the protein resulted in an inactive fraction. These features are most obvious from the production of a maximum of 0.32 equivalent of the succinate coproduct in the presence of excess 3, 2OG, and O 2 ( fig. S8, A and B) . The reaction of only one-third of the Fe(II) sites is also reflected in the accumulation of substoichiometric quantities of the intermediate states b and c (fig. S7) .
The intermediacy of a high-spin ferryl complex (Fig. 2C, state b) , which may be general to all Fe/2OG oxygenases (22) , is implied by Mössbauer spectra of a sample prepared by mixing the CarC•Fe(II)•2OG•3 complex at 5°C with excess O 2 and freeze-quenching after 0.15 s (Fig. 3B  and fig. S9 ). The spectrum at 4.2 K in an applied magnetic field of 53 mT (hash marks) exhibits a new feature at~1 mm/s that is not present in the spectrum of the reactant complex (Fig. 3A) . This feature is the high-energy line of a quadrupole doublet with isomer shift (d) of 0.28 mm/s and quadrupole splitting (DE Q ) of 0.87 mm/s (Fig. 3B,  solid line, and fig. S9 ), parameters very similar to those of high-spin (S = 2) ferryl complexes detected in other Fe/2OG oxygenases (37) (38) (39) (40) (41) . Spectra collected in an 8-T applied field ( fig.  S10 ) confirm that the Fe(IV) complex has a highspin ground state. The features of the complex account for 24% of the total intensity, equating to 0.24 equivalent relative to CarC•Fe(II) (Fig. 3C and  fig. S7 ). Its decay is accompanied by formation of high-spin (S = 5/2) Fe(III) species (Fig. 3C,  arrows, and fig. S10 ), consistent with formation of states c and d in Fig. 2C . Conversion of the ferryl complex to accumulating Fe(III) species, which is also reflected in absorption and electron paramagnetic resonance (EPR) spectra discussed below, contrasts with events in the catalytic oxidation reactions of other well-studied Fe/2OG oxygenases, in which the ferryl complexes decay back to Fe(II) species (37, 39, 41, 42) . As noted, this difference reflects the nonoxidative and stoichiometric nature of the stereoinversion reaction.
Stopped-flow absorption experiments initiated by mixing CarC•Fe(II)•2OG•3 with excess O 2 confirm that decay of the ferryl complex between 0.15 and 3 s is associated with accumulation of a tyrosyl radical (Fig. 2C, state c) . A sharp absorption feature at 410 nm and broader peak at 390 nm, unmistakable hallmarks of a tyrosyl radical (Y•), reach their maximum intensity at a (Fig. 4,  A and B) . The kinetics of formation and decay of the Y• (Fig. 4B, red trace) , deduced by the height of the 410-nm peak (Fig. 4A, orange markings) , are simulated well according to the kinetic mechanism in fig. S7 (compare red data and black simulation traces). The absorption in the ultraviolet region of the spectrum remaining after decay of the Y• (Fig. 4A, cyan trace) reflects the conversion of the Fe(II) cofactor to Fe(III) in the stoichiometric stereoinversion, as also revealed by the Mössbauer spectra. The enzyme reacts with O 2 much less rapidly, and no Y• accumulates, in analogous reactions lacking 3 in the protein reactant solution (Fig. 4B , compare red and orange traces). This activating effect of the substrate, which we have termed "substrate triggering," is common to the Fe/2OG oxygenases (22, 39) .
EPR spectra at 10 K of samples freeze-quenched at reaction times of 0.5, 3.0, and 30 s (Fig. 4C) exhibit a signal at g = 2.0 suggestive of an organic radical. The signal develops and decays with the same kinetics ( fig. S7, red circles) These 10-K EPR spectra have additional resonances at g = 4.28 and 6.95 ( fig. S11 ). The g = 4.28 signal develops slowly and is then stable, and we attribute it to the stable Fe(III) cofactor form(s) in state d of the productive reaction ( Fig. 2C and fig. S7 ) and perhaps also generated by slow oxidation of the Fe(II) in the two-thirds of the enzyme that fails to react productively. The g = 6.95 signal is transient and develops and decays along with the Y• ( fig. S11A ). It arises from the ground Kramers doublet of a high-spin (S = 5/2) Fe(III) center with a positive axial zerofield-splitting parameter (D > 0) and a rhombicity (E/D) of~0.05. Its characteristics associate it with the Fe(III) site present along with the Y• in state c (Fig. 2C) . Evidence for the expected interaction between the two paramagnetic species is provided by the temperature dependencies of the g = 6.95 and g = 2.0 signals. With increasing temperature from 10 to 100 K, the g = 6.95 signal of the Fe(III) ion becomes markedly less intense ( fig. S11B ). It broadens almost into the baseline at the higher temperatures as a result of more rapid spin-relaxation. Because the two species interact magnetically, the faster relaxation of the Fe(III) center affects the g = 2.0 signal of the Y•. At 100 K, the Y• signal is sharper than at 10 K and clearly exhibits the characteristic hyperfine interactions with the b-and ring hydrogens (Fig. 4C, gray trace,  and fig. S12 ). The faster spin-relaxation of the Fe(III) species at the higher temperature effectively decouples the spins of the two paramagnetic centers on the EPR time scale. The failure of the magnetic interaction with the Y• to perturb the Mössbauer spectra of the Fe(III) center is explained in the supplementary materials ( fig. S13) .
The results of stopped-flow experiments using 5-d-3 in place of 3 verify that conversion of b to c involves cleavage of the C5-H bond. The features of the Y• develop more slowly and to a much lesser extent with the deuterated substrate (Fig. 4B and  fig. S7 , compare blue and red traces). That the Y• forms more slowly reflects the deuterium kinetic isotope effect on abstraction of the C5 hydrogen and implies that Y• formation follows cleavage of this bond. That much less Y• accumulates implies that the H•-abstracting ferryl complex can decay by at least one additional, unproductive pathway (the downward branch from b to ? in fig. S7 ), which contributes to a minor extent in the reaction with 3 but becomes predominant when the (Fig. 4D , black trace) coeluting at 7.8 min with the acid-hydrolyzed substrate (red trace). As expected, no peak (or shoulder) is seen at 8.0 min, when the cis product from hydrolysis of 4 elutes (dark blue trace). The chromatogram for a sample quenched in formic acid 3 s after the CarC•Fe(II)•2OG•3 complex was mixed with excess O 2 (cyan trace) reveals a diminution in the peak at 7.8-min elution time corresponding to 12 (trans) and development of the broad peak at 8.0 min corresponding to 13 (cis), signifying conversion of 3 to 4. The corresponding chromatogram from a sample acid-quenched after reacting for just 0.15 s (when state b predominates) has only a small shoulder for 13 (light green trace), and the trace from the 10-s sample reveals little additional conversion occurring after 3 s, the time at which state c accumulates maximally. The results confirm that state b has 3 bound to the enzyme whereas state c has 4 bound.
The clear implication of the CarC•Fe(II)•2OG•3 structure-that Y165 is the H• donor and primary site of the Y•-is confirmed by the results of stopped-flow experiments on four variants of CarC each having one of the four Y residues in the halo of aromatic residues that encircles the substrate (Fig. 2B) (Fig. 4B , black, yellow, and cyan traces, respectively). The amplitudes and kinetics are perturbed to varying extents by the substitutions, consistent with auxiliary roles for these Y residues (e.g., in binding the substrate, in ensuring the proper conformation of the H•-donating Y, or in stabilizing the Y•). By contrast, no 410-nm signal develops in the reaction of the Y165F variant of CarC (dark green trace), and no conversion of 3 to 4 is detected in LC-MS analysis of the acid-quenched reaction products (as in Fig. 4D ). These observations confirm that Y165 is the H• donor and primary site of the radical. Figure 1B implies that H• donation to C5 diverts the CarC reaction from either of two possible catalytic oxidation outcomes (reactions i and iii) to the stoichiometric, redox-neutral stereoinversion (reaction ii). Consistent with this idea, the Y165F substitution defaults CarC back to a fully catalytic oxygenase. By contrast to the mediation of only 0.25 to 0.35 turnover by the wild-type enzyme, the Y165F variant protein effects minimally three turnovers under the same conditions, as seen by quantification of both succinate produced (figs. S8A, five rear traces, and S8B, red data points) and 3 consumed (fig. S8C, fig. S8D , we posit that the altered outcome is hydroxylation of C5 according to the classical "oxygen-rebound" mechanism (44), but the actual outcome remains to be determined. Regardless, the results establish that the H•-donating Y165 residue, brought into position by the substratedriven closure of a lid loop, is necessary and sufficient to direct the nonredox, stereoinversion outcome that distinguishes CarC from other Fe/2OG oxygenases and is required for the biosynthesis of all carbapenem antibiotics.
